Tag | Content |
---|
EnhancerAtlas ID | HS187-12200 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr19:30161680-30164730 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
MEF2A | MA0052.3 | chr19:30162545-30162557 | GCTAAAAATAGC | + | 6.44 | MEF2B | MA0660.1 | chr19:30162545-30162557 | GCTAAAAATAGC | + | 6.92 | MEF2C | MA0497.1 | chr19:30162543-30162558 | AAGCTAAAAATAGCA | + | 8.03 | NFE2L1 | MA0089.2 | chr19:30162847-30162862 | AGAGCTGAGTCATGC | - | 6.23 | REL | MA0101.1 | chr19:30164516-30164526 | GGAAATCCCC | - | 6.02 |
|
| Number of super-enhancer constituents: 23 | ID | Coordinate | Tissue/cell |
SE_01995 | chr19:30162190-30164011 | Aorta | SE_03500 | chr19:30162856-30163592 | Brain_Angular_Gyrus | SE_04418 | chr19:30161971-30164004 | Brain_Anterior_Caudate | SE_05104 | chr19:30161943-30175216 | Brain_Cingulate_Gyrus | SE_05992 | chr19:30161895-30175512 | Brain_Hippocampus_Middle | SE_07189 | chr19:30161916-30170161 | Brain_Hippocampus_Middle_150 | SE_08055 | chr19:30161921-30164788 | Brain_Inferior_Temporal_Lobe | SE_12389 | chr19:30161691-30165248 | CD3 | SE_15294 | chr19:30161517-30168364 | CD4_Memory_Primary_7pool | SE_16572 | chr19:30161499-30165474 | CD4_Naive_Primary_8pool | SE_18169 | chr19:30155285-30168956 | CD4p_CD25-_CD45ROp_Memory | SE_19560 | chr19:30161728-30168512 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20556 | chr19:30155335-30172521 | CD56 | SE_21321 | chr19:30161657-30165390 | CD8_Memory_7pool | SE_40973 | chr19:30161560-30165126 | Left_Ventricle | SE_41671 | chr19:30162218-30163132 | LNCaP | SE_41671 | chr19:30163219-30167352 | LNCaP | SE_42924 | chr19:30161733-30165058 | Lung | SE_48180 | chr19:30153054-30174554 | Psoas_Muscle | SE_48808 | chr19:30161040-30164995 | Right_Atrium | SE_49565 | chr19:30162474-30163503 | Right_Ventricle | SE_51595 | chr19:30160892-30165284 | Skeletal_Muscle | SE_55264 | chr19:30162098-30165400 | Thymus |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TTCACGCCAT TCTCCTGCCT CAGCCTCCCG AGTAGCTGGG ACTACAGGCG CTCGCCACCA 60 CACCAGGCTA ATTTTTTGTA TTTTAAGAGA CAGAGTTTCA CCGTGTTGGC CAGGATGGTC 120 TAGATCTCCT GACCTCATGA TCCCCCCTCC TCGGCCTCCC AAAGTGCTGG GATTACAGGC 180 GTGAGTATTT TTAACTTTTT AAGGAACTTC CATGCTGTTT TCCTTAGGGG CTGCACCAGT 240 TCCTATTCTC ATCAGCAGTG CACAGTTTCC AGTTTCTCCA CACCCTCACC AACACTTGTT 300 ATTTATTTTT TGTTTTGTTT TTTTCCCCTC CTTTTTTTTT TTTTGAGATG GAATCTCACT 360 CTGTCACACA GGCTGGAGTG CAATGGCGCC ATCTTGGCTC ACTGCAACCT CTGCTTCCTG 420 GGTTCAAGCG ATTCTCCTGC CTCCGCCTCC CGAGTAGCTG GAATTACAGG TGTGAGGCAC 480 TGTGTCCGGC CTTCCTCCTA CCTATTTTTA TTCATAGATA TAGTTCTTGA ACACTTTCAG 540 AATGTTATGT AATTCCTGCA TAAGTGGTGT CACTTTACAT ACAACATTCT ACAGGCTGTG 600 TTTTTCCACT CCACGTTTGT TGTTTGCCGT CAGACCACAT TGATCTGTAT CTCTCATTGC 660 GTGAGTAGCC CCGGGTTTTT ATCCTTTTCC CTGCTGGTAG GCATTTTGGT TGTCTCTGCT 720 GGGCAGTCAT TGCTCTTTGT GGAATGCAGT TCTGGTTTTG TCAGATTGTC CCTCAGCCAG 780 GTACTCGGTG ATCAGTCATG GTGGGACAGG TCAGTTCTGT CACTGGTAAT CCCCTAGGTT 840 TGCAGTATAC AGCCAAGATC AGCAAGCTAA AAATAGCAGT TCTTACGTAA GGTAGTGTGG 900 GCAGCCCTTC TCAGGACACT TGTGATCTGC AGGGGCAAGT GGAACGGGAC TCGAGGGCCC 960 AGCATCTTCT GTTCTGCAAT GCATCCACCC TCACACTGGG GCCCCACTCT GGCTTTCTAC 1020 TGGTGGCCAG GCTCAGAACT GCAGCTCAGT GACCCAGAAA CACTATGGGT GTGATCAGCT 1080 CAGCCCCAGG CGTGCCGTGT GTACCGGAAT GCATGTGTGC ACGTGGTGGT GGTGGGGCCA 1140 GCTCTCACCT CTTCCTCTGT AGAGGTAAGA GCTGAGTCAT GCATGGTGGG CCTTGGGACC 1200 TGCTTGGAAC CGTGCCAAGC TACTTATGAA GCATCTAGTA TGTGCTTGGC ATGGCTCCAA 1260 GAATTGTGGA CACAATGAAC AAGAAGAAGC TCCTGTTCTC ATGGAGCTAA GAACTGAGCA 1320 GGGAAGCAGA AAACACACAA GCAATGAATA GACAAGCAAA CAGCAGGTCC TGTTAAATCC 1380 CACAAAGAAA AACGATTGAA TCCCAGAGAA GTGGCCAGCA GACCTTTTCT ACAAAGGGCC 1440 AGGTGGTGAA TATTTTAGGC TTTGTCACCA TGTAGTCCCT GTCACCAACA CTCAACTCTC 1500 CCATTGCAGT GTGGAAGCCA CCAGAGACAA TAATAAATGA ACGAATGTGG CTGTGTCCCA 1560 ATAAATCTTT AACAAAAGCA GGCTGAGGGC CGGATTTGAC TCTCAGACCT TGGATTACCA 1620 ATGCTTGTCC TGGGTGTGGG AAGAGGCTGC CTGAGCTGGG GTTGTCAGGG AGAACCCTTT 1680 CAAAAAGGAA CTGAGAACCC GTTGCAGGAA GGAGCTGACC CTGGGACAGC CTGTCTCAGG 1740 TAGGACACAA TGGCACCTTG CCACCGATAT GGTGGCGGAG TTATGTGCTG AGAAATGGGC 1800 AGGCTAGATT TGAGAGGTAA AGATGATGAG ATTTACTCAT GGCTTGAATA TTGGAGGTAC 1860 AGGAAGGGGG AGATTCAAGG ATGTGTCCTA GGTCTGGGGT TTGAACTCCT GGATGAATGG 1920 TGGTGTCACT GAAGGAGAGG AAGAGGTGCA GGTCTGCGGA GGTTTGTTGT TGGATGTGTT 1980 GAGTTTGAGG AGCTTATTAG ACAAGCAGGT GAACATCTAT GCTGACAGCC CTCCTAGAGC 2040 TTGGAGAGGC CAAGACTGGA GGCTTGGAAT GGGGAATCTA TGGCATTTAT GGGGTCTTCA 2100 AGGTCGTGAG TCTGGTGGGC TGGTGTGTGT GTGGACCAAG CAGGGGGCGC CCGGCATGAG 2160 CTCTGAGTTA GTGCTTAGTG CTTAGGGCAC CAACAGAGGG GCCTGTGTGG CCTCACACTC 2220 CACTCGGGAC GGCAGCATAG TGCGAGCTCC AGGGCCCCTG CCTCCTAGCA TCGCCTCAGT 2280 TCCCCTCCTG TAAAGTGGGG ATTCTGCCTT CTGGGGTTGG GTGGGAACTA AATGAGATAG 2340 TCACGCTTGG CTGACAGGAA GCACTCGGCG CCTGTGCTTG TGATGGTGGT GGTGACTGCT 2400 GCACTTCCTG GGTGGTTGCG TGGGTTGCAG GGCCTGTGAC AGCTTGGTTT GGTGGATGGC 2460 AGAGTCAGGG TTGGGTTGGG GGTAGAGACA CCCAGGTCTC CTGGCACAGA CCGTTCTGAT 2520 GTCCCGTTGA GGCCTGTTCC GCCCTGTTTT TCAAGGCTCC CCAGCGGGGC TGAACCTCTG 2580 CCCTCTGCTG CCCACAGTAG TAGCCGGCTC AGTAGCACTT TTTTTTTTTA AGAGATAGAA 2640 TCCACTCAGT CACCTAGCTA GAGTGTAGTG GCATGATCAT AGCTCACTGT AGCCTCAAAC 2700 TCCTGGGCTC GAGCCTCCTC TTGCCTCAGC CTTCCAAAAC GCTGGAACCA CAGGCATGAA 2760 CCGCTGCACC TGGCCTAAGT AGCACACTTT ATCACTGCCT TCCCATCCCT GTCTGGCCTC 2820 CACATCCCCT TTACTGGGAA ATCCCCCTTC CCTCCCCGTA GTTCCCTGTA CTCCCGTCTA 2880 AGGGTCAGCT TCCGAGGTGA TGCTTCTCAG TGCTGGGCAG GCCTGCGGGT TACTGTGCGT 2940 AGTCAGTGGG CTGCCTGGCA TGGTGGGTTA GTCAGTTGGG GGTGGGCAGC GTGGTTCTGA 3000 CACCCCCATG CCTGAGCCTG GACATACTCC TTGTCTGTCT CCTCCTGCAG 3050
|